Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
NCT00062400 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 385
Last updated 2026-05-12
Summary
RATIONALE: Adjuvant therapy given after surgery for early breast cancer may cause infertility. Assessing young women's attitudes and feelings about the risk of infertility may help improve the ability to plan effective treatment.
PURPOSE: This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
Conditions
- Breast Cancer
- Psychosocial Effects of Cancer and Its Treatment
- Sexual Dysfunction and Infertility
- Sexuality and Reproductive Issues
Interventions
- PROCEDURE
-
psychosocial assessment and care
Sponsors & Collaborators
-
German Adjuvant Breast Cancer Group
collaborator OTHER -
ETOP IBCSG Partners Foundation
collaborator NETWORK -
European Organisation for Research and Treatment of Cancer - EORTC
lead NETWORK
Principal Investigators
-
Zora Neskovic-Konstantinovic · Institute Of Oncology & Radiology, Belgrade, Serbia
Study Design
- Purpose
- OTHER
Eligibility
- Min Age
- 0 Years
- Max Age
- 35 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-05-31
- Primary Completion
- 2008-06-30
- Completion
- 2008-06-30
Countries
- Belgium
- Chile
- Croatia
- Germany
- Italy
- Lebanon
- Netherlands
- Peru
- Poland
- Portugal
- Serbia
- South Africa
- Switzerland
- Turkey (Türkiye)
- United Kingdom
Study Locations
More Related Trials
-
Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer
NCT01781338 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 ·Status: UNKNOWN
-
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
NCT00309569 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
NCT00068328 ·Status: COMPLETED
-
Trial of Perioperative Endocrine Therapy - Individualising Care
NCT02338310 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
NCT02300675 ·Status: COMPLETED ·Phase: NA
-
Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea
NCT02132390 ·Status: UNKNOWN ·Phase: PHASE3
-
Impact of Sequential Chemotherapy on Young Patients Breast Cancer Treated Fertility
NCT01614704 ·Status: TERMINATED
-
Correlation of Menstrual Cycle Phase at Time of Primary Surgery With 5-Year Disease-Free Survival in Women With Stage I or Stage II Breast Cancer
NCT00002762 ·Status: COMPLETED
-
Interactive Care Plan for the Monitoring of Symptoms and Recovery in Patients With Stage 0-III Breast Cancer
NCT04693338 ·Status: COMPLETED ·Phase: PHASE1
-
Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer
NCT04586686 ·Status: UNKNOWN ·Phase: NA
-
Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women
NCT00186121 ·Status: COMPLETED ·Phase: PHASE2
-
Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer
NCT00078832 ·Status: COMPLETED ·Phase: PHASE3
-
Pre-Surgical Intervention for Targeted Therapies for Breast Cancer
NCT01004744 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer
NCT04142476 ·Status: TERMINATED ·Phase: NA
-
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
NCT00542594 ·Status: TERMINATED
-
Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy
NCT07232056 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
EXamining PErsonalised Radiation Therapy for Low-risk Early Breast Cancer
NCT02889874 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT00002460 ·Status: UNKNOWN ·Phase: PHASE3
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Letrozole in Treating Postmenopausal Women With Estrogen-Receptor Positive and/or Progesterone-Receptor Positive Stage II, Stage IIIA, or Stage IIIB Breast Cancer
NCT00084396 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer
NCT03747042 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer
NCT00077025 ·Status: COMPLETED ·Phase: PHASE2